KylePEtzkornMDFACP, CPI
Gastroenterology • Jacksonville, FLAdvanced Endoscopic Interventional, Gastrointestinal Cancer, Hepatology & Liver Transplantation
CEO of Borland-Groover Clinic
Dr. Etzkorn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4800 Belfort Rd
Jacksonville, FL 32256Phone+1 904-398-7205Fax+1 904-396-4047
Education & Training
University of Illinois College of Medicine at ChicagoFellowship, Advanced Endoscopy, 1993 - 1994
University of Texas Health Science Center at HoustonFellowship, Gastroenterology, 1991 - 1993- University of Illinois College of Medicine at ChicagoResidency, Internal Medicine, 1988 - 1990
University of ChicagoInternship, Psychiatry, 1987 - 1988
University of Missouri Kansas City School of MedicineClass of 1987
Certifications & Licensure
FL State Medical License 1996 - 2026
IL State Medical License 1987 - 2014- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2011-2013
- Top Doctors: Florida Castle Connolly, 2000
Publications & Presentations
PubMed
- 145 citationsSimeprevir plus sofosbuvir (12 and 8 weeks) in hepatitis C virus genotype 1-infected patients without cirrhosis: OPTIMIST-1, a phase 3, randomized studyPaul Y. Kwo, Norman Gitlin, Ronald Nahass, David E. Bernstein, K.P. Etzkorn
Hepatology. 2016-08-01 - 143 citationsA phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy.Douglas K. Rex, Raj Bhandari, Taddese Desta, Michael P. DeMicco, Cynthia Schaeffer
Gastrointestinal Endoscopy. 2018-09-01 - 46 citationsEfficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Hepatitis C Virus Genotype 2, 3, 4, or 6 Infections in an Open-Label, Phase 2 Trial.Edward Gane, Kris V. Kowdley, David Pound, Catherine A.M. Stedman, M. Davis
Gastroenterology. 2016-11-01
Press Mentions
OMNY Health Launches New GI Real-World Data Solutions in Partnership with Leading US Gastroenterology PracticesApril 22nd, 2024- Borland Groover Breaks Ground on St. Johns Surgery CenterOctober 28th, 2020
- OMNY Health Launches New GI Real-World Data Solutions in Partnership with Leading US Gastroenterology PracticesApril 23rd, 2024
Other Languages
- German
External Links
- Borland Groover Clinichttp://Borland-Groover.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
